Intellectual Property India Publishes Patent Application for 'Tissue Factor Antibody-Drug Conjugates And Uses Thereof' Filed by Exelixis, Inc.

MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202517027336 A) filed by Exelixis, Inc., Alameda, U.S.A., on March 24, for 'tissue factor antibody-drug conjugates and uses thereof.'

Inventor(s) include Barfield, Robyn, M.; Bauzon, Maxine; Drake, Penelope, M.; Kantak, Seema; Mendelsohn, Brian, Alan; and Unsulangi, Tiffany.

The application for the patent was published on May 2, under issue no. 18/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides anti-tissue factor antibody-drug conjugate structures. The antibody-drug conjugate structures include a branched linker, where two or more payloads per branched linker are attached to an antibody. In...